Gloria Lee

Gloria Lee, MD, PhD
Chief Medical Officer

Dr. Lee is an expert in oncology drug development. Working in big pharma and biotech settings, she has taken products from early clinical development to marketing approval. Read More >

Curtis Tyree

Curtis Tyree, PhD
Senior Vice President, Strategic Planning

Dr. Tyree is responsible for the operational management of company programs and evaluation of candidates from HUYA’s database of China-sourced therapeutic opportunities. Dr. Tyree has over 22 years drug discovery experience in oncology, cardiology, inflammatory disease, and neurology. Read More >

Elizabeth Song

Elizabeth S. Song, PhD
Senior Vice President, Business Development

Dr. Song is responsible for in-and out-licensing of HUYA pipeline candidates and managing alliances with partners. She has extensive experience in business development at established and emerging companies, with an outstanding track record of creative deal making to generate cash, accelerate product development, and leverage relationships to increase post-deal success. Read More >

Suzanne Romano

Suzanne Romano, PhD
Vice President, Product Evaluation & Early Stage Development

Dr. Romano is responsible for evaluation and preclinical development of HUYA’s in-licensed drug candidates. Dr. Romano has “hands-on” as well as management experience from pharmaceutical and biotech companies. Read More >

Reid Bissonnette

Reid Bissonnette, PhD
Vice President, Pharmacology

Dr. Bissonnette oversees pharmacology and translational activities supporting the advancement of HUYA’s lead candidates and contributes to the assessment of new therapeutic opportunities in oncology and inflammation. Dr. Bissonnette has more than 20 years of drug discovery experience in oncology, inflammation and immunology, and has experience in small molecules, peptides, biologics and drug conjugates. Read More >

Chris Kemmerer

Christopher Kemmerer, PhD
Vice President, Chemistry, Manufacturing and Controls

Dr. Kemmerer leads the chemistry, manufacturing, and controls (CMC) functions for HUYA’s in-licensed drug candidates. Dr. Kemmerer specializes in formulation and process development, scale-up and tech transfer, and manufacturing. Read More >